SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-09-005769
Filing Date
2009-05-18
Accepted
2009-05-18 09:02:23
Documents
4
Effectiveness Date
2009-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2193168zdefa14a.htm DEFA14A 28157
2 G643846.JPG g643846.jpg GRAPHIC 4041
3 G557101.JPG g557101.jpg GRAPHIC 7143
4 G158543.JPG g158543.jpg GRAPHIC 5114
  Complete submission text file 0001047469-09-005769.txt   52466
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19700 | Film No.: 09835412
SIC: 2834 Pharmaceutical Preparations